oxazoles has been researched along with obeticholic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Attia, SL; Mouzaki, M; Softic, S | 1 |
Deng, Q; Feng, S; Li, J; Pan, G; Wu, Z; Yang, W; Zhang, T | 1 |
1 review(s) available for oxazoles and obeticholic acid
Article | Year |
---|---|
Evolving Role for Pharmacotherapy in NAFLD/NASH.
Topics: Adult; Benzhydryl Compounds; Chenodeoxycholic Acid; Child; Clinical Trials, Phase III as Topic; Fibroblast Growth Factors; Glucosides; Humans; Imidazoles; Isobutyrates; Liraglutide; Liver; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Oxazoles; Polyethylene Glycols; Pyridazines; Pyrimidines; Severity of Illness Index; Sulfoxides; Treatment Outcome; Uracil | 2021 |
1 other study(ies) available for oxazoles and obeticholic acid
Article | Year |
---|---|
Farnesoid X receptor (FXR) agonists induce hepatocellular apoptosis and impair hepatic functions via FXR/SHP pathway.
Topics: Animals; Apoptosis; Chenodeoxycholic Acid; Liver Neoplasms, Experimental; Mice; Oxazoles; Phosphatidylinositol 3-Kinases; Receptors, Cytoplasmic and Nuclear; Signal Transduction | 2022 |